Sivelestat for septic shock with clotting problems
Treatments studied
Part of Blood & lymphatic, Heart & circulation, Infections clinical trials.
This trial tests a drug called sivelestat to see if it can help people with severe infections who also have blood clotting problems. The drug may reduce the risk of organ damage and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You are in the intensive care unit with a severe infection (septic shock) that requires medication to maintain blood pressure.
- You have a blood clotting problem related to the infection, as determined by a standard scoring system.
- The blood clotting problem was diagnosed within the last 12 hours before the study could start.
- You do not have severe liver disease (cirrhosis), are not pregnant or breastfeeding, and do not have any other condition that would make the study unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find early signs of a serious blood-clotting problem that can happen with septic shock. It tests a new way to detect this condition earlier, so doctors can treat it more quickly and improve outcomes.
This study tests a new medicine called BAY 3389934 to see if it's safe and what dose works best for people with sepsis and blood clotting issues. The goal is to improve blood clotting and help you recover from the infection.
This trial tests whether a combination of vitamins B6, B12, and C can help improve blood flow in tiny blood vessels (microcirculation) for people with sepsis. It may help your body recover better from severe infection.
This trial tests a blood-filtering device (CytoSorb) that may help control the overwhelming immune response and improve blood vessel function in people with severe septic shock. It's for patients who need strong medications to keep their blood pressure up and who haven't improved with standard care.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This study tests an investigational fluid called VBI-S to see if it can help raise blood pressure in people with septic shock who are not responding to standard fluids. You may qualify if you have severe infection and low blood pressure that needs medication support.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.